
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
(Associate) Director Protein & ADC Drug Substance
Shanghai, China | full time | Job ID: 11127
About the role:
- The main responsibility of this role is to provide project overarching drug substance support (mainly protein purification and ADC bioconjugation) and serve as a local interface for all clinical CMC project teams with Chinese collaboration partners, CDMOs, and vendors. In addition, the (Associate) Director Protein & ADC Drug Substance may also take dedicated responsibility as drug substance lead within global development projects.
- Specific tasks of this position include engaging directly with local collaboration partners, CDMOs, vendors, etc. to support drug substance development and GMP manufacturing for protein and ADC projects. This role also involves supporting operational & troubleshooting activities on-site
- The (Associate) Director Protein & ADC Drug substance will also support technical transfers to in-China and ex-China sites (focus clinical phase), internal audits, and Health Authority inspections
- As cultural and operational facilitators for the CMC teams, the (Associate) Director Protein & ADC Drug substance will leverage his/her language skills and local knowledge to resolve issues promptly. This role will also closely collaborate with Product Supply and Quality counterparts to enable efficient technical project handover to commercial operations
Your main responsibilities are:
- On-site operational support at collaboration partners and CDMOs for Drug Substance process development and clinical GMP production (person in plant, ad-hoc site visits for troubleshooting etc.)
- Review project documentation, including development reports, risk analysis, qualification/validation reports, batch records and release documentation according to regulatory guideline
- Translation of technical documents for technical transfer as well as due diligence activities
- Organization of technical visits at collaboration partners or CDMOs (project-related visits, technical transfers, due diligence, etc.)
- Subject matter expert support for internal audits and Health Authority inspections
A good match:
- Master’s degree in chemistry, Biopharmaceuticals, Biochemistry, Biology, or a comparable field with at least 5 years of relevant professional experience in an international and highly regulated environment
- Proven experience in m Ab and ADC Drug Substance process technologies with preferably specific operational experience in m Ab DSP or ADC bioconjugation
- Sound experience in CMC development of early- and late-stage projects, including strategy definition and strategy execution, with a sound understanding of all stages the drug development process
- Sound GMP knowledge and experience with regulatory filings for biologicals (IND/IMPD, BLA/MAA)
- Excellent project management skills, capable of working in cross-functional CMC teams and with external stakeholders
- Excellent communication and negotiation skills as well as ability to communicate complex technical matters in a clear and concise way to various stakeholders
Your Benefits:
BioNTech is committed to the wellbeing of our team members and offers a variety of benefits in support of our diverse employee base. We offer competitive remuneration packages which is determined by the specific role, location of employment and also the selected candidate’s qualifications and experience.
Note: The availability, eligibility and design of the listed benefits may vary depending on the location. The final requirements for the individual use of our benefits are based on the company's internal policies and applicable law.
How to apply:
Apply now by sending us your application documents including Curriculum Vitae, copy of ID, copies of degree certificates and professional certificates, motivation letter as well as your contact details via our online form.
Please note:
Only applications sent via our online form shall be considered. By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
We are looking forward receiving your application.
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Similar jobs

Technical lead - AutoSAR, Canoe, C
HCL Technologies

Static Timing Analysis Manager, Full Chip, SOC, Implementation

Lead Design Engineer (m/f/d) New Product Development of Medical Devices
Stryker · Schönkirchen, Germany

Architecture Group Manager
Citigroup · IRVING, Texas, United States of America

TECHNICAL LEAD L1
Wipro · Bengaluru, India
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
10 reviews
4.0
10 reviews
Work-life balance
2.8
Compensation
3.7
Culture
4.2
Career
3.5
Management
3.3
78%
Recommend to a friend
Pros
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
Cons
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
Salary Ranges
38 data points
L2
L6
Mid/L4
Intern
L3
L4
L5
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
Latest updates
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
2w ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
2w ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3w ago